These 4 Indian Pharma Stocks will give good return between Tariff Trade War | Paisa Live


If your portfolio has Pharma stocks, then these news is very important for coming because there may be many big announcements. Us President Donald Trump is not taking the name of the Tariff. Trump applied 26% tariff rate on India but kept the Pharma Sector untouched but 8 April the Donald Trump itself announced the installation of tariffs on Pharmaceutical Companies and since which has been a tension in Pharma Companies. This tariff will affect both India and US countries. Indian pharma manufacturers earn from 30% to 50% from American Market. Let us talk about India’s 4 Indian Pharmaceutical Firms, whose stocks can be on high risk due to the tariff. So Dr Reddy’s Laboratories, Aurobindo Pharma, Zydus Lifescienes and Sun Pharma. Will it be right to buy these stocks during this Trade War, watch the video to know.



Source link

support@headlinenews360.com

Related Posts

FPIs withdraw Rs 31,575 cr from Indian equities in April amid US tariff turmoil – Times of India

NEW DELHI: Foreign Portfolio Investors (FPIs) have pulled out Rs 31,575 crore from Indian equity markets so far in April, spooked by mounting global uncertainty stemming from sweeping tariffs imposed…

The stock market will open only three days next week, know which day will trading be trading?

Share Market: The stock market on Friday saw a boom after US President Donald Trump announced a 90 -day ban on tariffs. The market remained bright throughout the day. The…

Leave a Reply

Your email address will not be published. Required fields are marked *